Roger W. Watson

The recent declaration from the Food and Drug Administration (FDA) concerning non-approved thyroid treatments has led to a complicated and sometimes inconsistent scenario for both patients and medical professionals. The agency has issued a significant alert about the potential safety hazards linked to these medications, particularly a type of "animal-derived thyroid" (ADT) products. At the same time, the FDA has expressed its plan to "maintain accessibility" to these exact medications, at least for a temporary phase. This dual communication highlights the fragile equilibrium the FDA must maintain between its duty to safeguard public health and its obligation to avoid disrupting…

A recent study suggests that incorporating just 3,000 steps a day at a brisk pace could significantly reduce the risk of developing cardiovascular disease. The research highlights the importance of not just the quantity of steps but also their intensity. This finding provides a powerful, actionable insight for individuals looking to improve their heart health without committing to an extensive or time-consuming exercise regimen. It reinforces the idea that even moderate, consistent physical activity can yield substantial health benefits.The study, which analyzed data from thousands of participants, focused on the relationship between daily step count, walking speed, and cardiovascular health…

An increasing trend in employing GLP-1 receptor agonists for losing weight includes a method called "microdosing." This trial method, which involves consuming doses smaller than those usually prescribed of these widely-used drugs, is being embraced by certain individuals aiming to minimize adverse effects, lower expenses, or pursue a slower weight reduction. Nonetheless, this tactic is surrounded by considerable controversy, and healthcare experts are diligently assessing the potential advantages in relation to numerous significant dangers.The appeal of microdosing is primarily driven by a desire to mitigate the common, and often severe, gastrointestinal side effects associated with the standard therapeutic doses of…